Synlogic

$3.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

$0.00 (0.00%) As of 6:03 PM UTC today

Why Robinhood?

You can buy or sell Synlogic and other stocks, options, and ETFs commission-free!

About SYBX

Synlogic, Inc. engages in the discovery and development of Synthetic Biotic medicines. It focuses in Phenylketonuria, Enteric Hyperoxaluria, Immuno Oncology solid tumors, inflammatory bowel disease, and vaccines and other inflammatory programs.

CEO
Aoife M. Brennan
Employees
72
Headquarters
Cambridge, Massachusetts
Founded
2017
Market Cap
139.18M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
774.83K
High Today
$3.40
Low Today
$3.27
Open Price
$3.38
Volume
171.55K
52 Week High
$5.11
52 Week Low
$1.74

SYBX Earnings

-$0.48
-$0.32
-$0.16
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 7, Pre-Market

You May Also Like

ASB-D
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure